Cargando…

Effects of Resveratrol and Morin on Insoluble Tau in Tau Transgenic Mice

Tauopathies are neurodegenerative diseases, including Alzheimer’s disease (AD) and frontotemporal dementia (FTD), in which tau protein aggregates within neurons. An effective treatment is lacking and is urgently needed. We evaluated two structurally similar natural compounds, morin and resveratrol,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Kwun Chung, Kwan, Ping, Cheung, Stanley K.K., Ho, Amy, Baum, Larry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter Open 2018
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234473/ https://www.ncbi.nlm.nih.gov/pubmed/30479844 http://dx.doi.org/10.1515/tnsci-2018-0010

Ejemplares similares

Anti-tau antibody reduces insoluble tau and decreases brain atrophy
por: Yanamandra, Kiran, et al.
Publicado: (2015)

CHIP-mediated hyperubiquitylation of tau promotes its self-assembly into the insoluble tau filaments
por: Kim, Ji Hyeon, et al.
Publicado: (2021)

Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers
por: Cowan, Catherine M., et al.
Publicado: (2015)

Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy
por: Congdon, Erin E., et al.
Publicado: (2016)

Acetylation of Tau Induces Alzheimer's Disease-Associated Tau in Transgenic Mice
por: Ali, Addison, et al.
Publicado: (2021)

Acetylation of Tau Induces Alzheimer's Disease-Associated Tau in Transgenic Mice
por: Ali, Addison, et al.
Publicado: (2021)

A driver or a passenger? D421-caspase cleaved tau is associated with aggregated and insoluble tau
por: Gibson, Yolanda, et al.
Publicado: (2013)

Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
por: Ozcelik, Sefika, et al.
Publicado: (2013)

Increased Tau Phosphorylation and Tau Truncation, and Decreased Synaptophysin Levels in Mutant BRI(2)/Tau Transgenic Mice
por: Garringer, Holly J., et al.
Publicado: (2013)

Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden
por: O'Leary, John C, et al.
Publicado: (2010)

Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
por: Hosokawa, Masato, et al.
Publicado: (2012)

Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice
por: Ohia-Nwoko, Odochi, et al.
Publicado: (2014)

Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice
por: Bajracharya, Rinie, et al.
Publicado: (2021)

Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions
por: Pandit, Rucha, et al.
Publicado: (2019)

Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice
por: Zhong, Suyue, et al.
Publicado: (2023)

Inhibitory effect of morin on aldolase 2 from Eimeria tenella
por: Hu, Junjing, et al.
Publicado: (2022)

N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
por: Schlegel, Kerstin, et al.
Publicado: (2019)

Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
por: McCollum, Lauren E., et al.
Publicado: (2021)

Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology
por: Yang, Sujeong, et al.
Publicado: (2015)

Presence of insoluble Tau following rotenone exposure ameliorates basic pathways associated with neurodegeneration
por: Chaves, Rodrigo S., et al.
Publicado: (2016)

Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice
por: Kondak, Constantin, et al.
Publicado: (2023)

Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
por: Bi, Mian, et al.
Publicado: (2011)

Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice
por: Xia, Yuxing, et al.
Publicado: (2022)

Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau
por: Schweighauser, Manuel, et al.
Publicado: (2023)

High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology()
por: Knight, Elysse M., et al.
Publicado: (2014)

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
por: Eckenweber, Florian, et al.
Publicado: (2020)

The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
por: Valencia, Antonio, et al.
Publicado: (2021)

Co-expression network analysis of human tau-transgenic mice reveals protein modules associated with tau-induced pathologies
por: Tsumagari, Kazuya, et al.
Publicado: (2022)

NPT088 reduces both amyloid-β and tau pathologies in transgenic mice
por: Levenson, Jonathan M., et al.
Publicado: (2016)

Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
por: Höllerhage, Matthias, et al.
Publicado: (2014)

Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
por: Clavaguera, Florence, et al.
Publicado: (2013)

Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model
por: Riedel, Gernot, et al.
Publicado: (2020)

Imaging the accumulation and suppression of tau pathology using multiparametric MRI
por: Holmes, Holly E., et al.
Publicado: (2016)

Tau phosphorylation affects its axonal transport and degradation
por: Rodríguez-Martín, Teresa, et al.
Publicado: (2013)

Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice
por: Hoffmann, Nadine A, et al.
Publicado: (2013)

Correction: Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
Publicado: (2015)

Kainic acid hyperphosphorylates tau via inflammasome activation in MAPT transgenic mice
por: Zheng, Xiang-Yu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dplnsoh9fu83m7iv4mjfn6fmm1